Abstract:Background: Transplant renal artery stenosis (TRAS) after renal transplantation is a common cause of graft dysfunction and failure. Endovascular intervention in the form of percutaneous transluminal angioplasty (PTA) and stenting has rapidly become the dominant treatment modality for the TRAS. There is a paucity of clinical data on the use of drug-eluting stent (DES) for TRAS. We investigated the outcomes of patients with clinically significant TRAS undergoing DES placement. Methods: A retrospective review of patients with clinically significant TRAS undergoing PTA with DES placement from June 2014 to April 2021 was conducted. Patients treated for TRAS exhibited uncontrolled hypertension and/or unexplained allograft dysfunction. Patient demographics, procedural details, and follow-up outcomes were collected. Primary endpoints were the in-stent primary patency and graft survival. Secondary endpoints were freedom from reintervention, primary-assisted patency, and access-related complications. Results: Thirteen TRAS in 12 patients with graft function alteration were treated with DES. The median age was 57 years (interquartile range (IQR), 48-63 years), and 9 (70%) patients were male. The median follow-up was 9 months (IQR, 4-52 months). The most common comorbidity was hypertension (100%), coronary artery disease (83%), and diabetes. The median time from deceased donor transplant to intervention was 5.8 months (IQR, 3.5-6.7 months). TRAS was most commonly found at the juxta-ostial segment (77%). The procedure was performed with carbon dioxide angiography with minimal amount of iodinated contrast (median, 3 mL) under local anesthesia in 9 (69%), and general anesthesia in 4 (31%) patients. The median stent diameter was 4.5 mm (IQR, 4-5 mm), and the median stent length was 15 mm (IQR, 15-18 mm). No intraoperative complications occurred. The rates of stenosis-free primary patency of the DES and graft survival were 76% and 100%, respectively. All 3 reinterventions for restenosis resulted from the kinking of the transplant renal artery proximal to the DES, which were treated by extending the stent more proximally 1-2 mm into the external iliac artery. There were no access-related complications. The median time to reintervention was 0.9 months (range, 0.23-2 months). Freedom from reintervention and primary-assisted patency were 76% and 100%, respectively. Conclusions: Our study demonstrates that DES is a safe and effective treatment modality in patients with TRAS at short to mid-term follow-up. As all reinterventions after DES were performed due to kinking of the transplant renal artery proximal to the stent, bridging of the DES 1-2 mm into the external iliac artery is recommended.

Retrospective study on diagnosis and treatment of patients with early-stage renal artery stenosis after allograft kidney transplantation

Diabetes Insipidus-Like State Complicating Percutaneous Transluminal Renal Stenting for Transplant Renal Artery Stenosis.

Diagnosis and Management of Renal Artery Stenosis in the Transplant

Short-Term Outcomes Using a Drug-Coated Balloon for Transplant Renal Artery Stenosis

Graft survival after percutaneous transluminal renal stenting for transplant renal artery stenosis (TRAS) is worse compared to matched cadaveric grafts without TRAS

Endovascular treatment for transplant renal artery stenosis: ten years' experience from a single center

Perfusion and oxygenation in allografts with transplant renal artery stenosis: Evaluation with functional magnetic resonance imaging

Clinical Application of Color Doppler Flow Imaging for Diagnosis of Transplant Renal Artery Stenosis

Retrospective analysis of percutaneous intervention of the renal artery in transplanted kidneys in children and adolescents at a tertiary public hospital

Clinical Application Value of Color Doppler Flow Imaging for Evaluating Transplant Renal Artery Stenosis

Application of contrast-enhanced ultrasound in evaluating the degree of transplant renal artery stenosis

Clinical Efficacy of PTRAS in Treatment of Atherosclerotic Renal Artery Stenosis

Transplant Renal Artery Stenosis: Evaluation with Contrast-Enhanced Ultrasound.

Two masqueraders of transplant renal artery Stenosis (TRAS)

Assessment of Transplant Renal Artery Stenosis with Non-contrast-Enhanced Magnetic Resonance Angiography: Comparison with Digital Subtraction Angiography.

Safety and Efficacy of Drug Eluting Stents for Treatment of Transplant Renal Artery Stenosis

Clinical value of contrast-enhanced ultrasound in evaluating short-term outcome of stent implantation for transplant renal artery stenosis

Renal Dynamic Imaging for the Treatment Assessment of Renal Artery Angioplasty and Stenting in Patients with Atherosclerotic Renal Artery Stenosis

Dynamic changes of renal cortical blood perfusion before and after percutaneous transluminal renal artery stenting in patients with severe atherosclerotic renal artery stenosis

Hemodynamics in Transplant Renal Artery Stenosis and its Alteration after Stent Implantation Based on a Patient-specific Computational Fluid Dynamics Model

Zero-contrast PTRA and stenting for child with TRAS: A case report